In contrast to aggressive and fast-growing tumor types, such as lung adenocarcinoma, a previous study demonstrated variations in Prdx5 mRNA levels as prognostic factors in lung cancer, with low levels of Prdx5 correlating with poor overall survival [70]. Here, PRDX5 is linked to lung cancer.